Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Gulyás B[au]:

The gut microbiota influences blood-brain barrier permeability in mice. Braniste V et al. Sci Transl Med. (2014)

27-Hydroxycholesterol impairs neuronal glucose uptake through an IRAP/GLUT4 system dysregulation. Ismail MA et al. J Exp Med. (2017)

An Overview of Multimodal Neuroimaging Using Nanoprobes. Sridhar S et al. Int J Mol Sci. (2017)

Search results

Items: 1 to 50 of 236

1.

The gut microbiota influences skeletal muscle mass and function in mice.

Lahiri S, Kim H, Garcia-Perez I, Reza MM, Martin KA, Kundu P, Cox LM, Selkrig J, Posma JM, Zhang H, Padmanabhan P, Moret C, Gulyás B, Blaser MJ, Auwerx J, Holmes E, Nicholson J, Wahli W, Pettersson S.

Sci Transl Med. 2019 Jul 24;11(502). pii: eaan5662. doi: 10.1126/scitranslmed.aan5662.

2.

Codon usage of human hepatitis C virus clearance genes in relation to its expression.

Singh P, Venkatesan A, Padmanabhan P, Gulyas B, Dass J FP.

J Cell Biochem. 2019 Jul 16. doi: 10.1002/jcb.29290. [Epub ahead of print]

PMID:
31310376
3.

Performance Evaluation of a High Resolution Non-Human Primate PET/CT System.

Sarnyai Z, Nagy K, Patay G, Molnár M, Rosenqvist G, Tóth M, Takano A, Gulyás B, Major P, Halldin C, Varrone A.

J Nucl Med. 2019 Jul 13. pii: jnumed.117.206243. doi: 10.2967/jnumed.117.206243. [Epub ahead of print]

PMID:
31302634
4.

Muscle extract of Arothron immaculatus regulates the blood glucose level and the antioxidant system in high-fat diet and streptozotocin induced diabetic rats.

Kaleshkumar K, Rajaram R, Gayathri N, Sivasudha T, Arun G, Archunan G, Gulyás B, Padmanabhan P.

Bioorg Chem. 2019 Sep;90:103072. doi: 10.1016/j.bioorg.2019.103072. Epub 2019 Jun 21.

PMID:
31260877
5.

Synthesis and biological evaluation of [18F]fluorovinpocetine, a potential PET radioligand for TSPO imaging.

Nag S, Krasikova R, Airaksinen AJ, Arakawa R, Petukhovd M, Gulyas B.

Bioorg Med Chem Lett. 2019 Aug 15;29(16):2270-2274. doi: 10.1016/j.bmcl.2019.06.037. Epub 2019 Jun 20.

PMID:
31257082
6.

Bifunctional Fluorescent/Raman Nanoprobe for the Early Detection of Amyloid.

Xia Y, Padmanabhan P, Sarangapani S, Gulyás B, Vadakke Matham M.

Sci Rep. 2019 Jun 11;9(1):8497. doi: 10.1038/s41598-019-43288-2.

7.

In vitro phosphodiesterase 10A (PDE10A) binding in whole hemisphere human brain using the PET radioligand [18F]MNI-659.

Svedberg MM, Varnäs K, Varrone A, Mitsios N, Mulder J, Gulyás B, Beaumont V, Munoz-Sanjuan I, Zaleska MM, Schmidt CJ, Halldin C, Mrzljak L.

Brain Res. 2019 May 15;1711:140-145. doi: 10.1016/j.brainres.2019.01.021. Epub 2019 Jan 18.

PMID:
30664847
8.

PET-MR and SPECT-MR multimodality probes: Development and challenges.

Yang CT, Ghosh KK, Padmanabhan P, Langer O, Liu J, Eng DNC, Halldin C, Gulyás B.

Theranostics. 2018 Nov 29;8(22):6210-6232. doi: 10.7150/thno.26610. eCollection 2018. Review.

9.

Theranostic applications of nanoparticles in neurodegenerative disorders.

Ramanathan S, Archunan G, Sivakumar M, Tamil Selvan S, Fred AL, Kumar S, Gulyás B, Padmanabhan P.

Int J Nanomedicine. 2018 Sep 20;13:5561-5576. doi: 10.2147/IJN.S149022. eCollection 2018. Review.

10.

Lineage-specific exosomes could override extracellular matrix mediated human mesenchymal stem cell differentiation.

Narayanan K, Kumar S, Padmanabhan P, Gulyas B, Wan ACA, Rajendran VM.

Biomaterials. 2018 Nov;182:312-322. doi: 10.1016/j.biomaterials.2018.08.027. Epub 2018 Aug 11.

PMID:
30153612
11.

Author Correction: Buffalo nasal odorant-binding protein (bunOBP) and its structural evaluation with putative pheromones.

Muthukumar S, Rajesh D, Selvam RM, Saibaba G, Suvaithenamudhan S, Akbarsha MA, Padmanabhan P, Gulyas B, Archunan G.

Sci Rep. 2018 Aug 1;8(1):11785. doi: 10.1038/s41598-018-29894-6.

12.

Misfolded Protein Linked Strategies Toward Biomarker Development for Neurodegenerative Diseases.

Kumar S, Karthikeyan N, Mishra S, Padmanabhan P, Radda G, Gulyás B.

Mol Neurobiol. 2019 Apr;56(4):2559-2578. doi: 10.1007/s12035-018-1232-4. Epub 2018 Jul 24. Review.

PMID:
30043261
13.

Peripheral Biomarkers for Early Detection of Alzheimer's and Parkinson's Diseases.

Htike TT, Mishra S, Kumar S, Padmanabhan P, Gulyás B.

Mol Neurobiol. 2019 Mar;56(3):2256-2277. doi: 10.1007/s12035-018-1151-4. Epub 2018 Jul 14. Review.

PMID:
30008073
14.

PET/MRI: a frontier in era of complementary hybrid imaging.

Musafargani S, Ghosh KK, Mishra S, Mahalakshmi P, Padmanabhan P, Gulyás B.

Eur J Hybrid Imaging. 2018;2(1):12. doi: 10.1186/s41824-018-0030-6. Epub 2018 Jun 25. Review.

15.

Buffalo nasal odorant-binding protein (bunOBP) and its structural evaluation with putative pheromones.

Muthukumar S, Rajesh D, Selvam RM, Saibaba G, Suvaithenamudhan S, Akbarsha MA, Padmanabhan P, Gulyas B, Archunan G.

Sci Rep. 2018 Jun 19;8(1):9323. doi: 10.1038/s41598-018-27550-7. Erratum in: Sci Rep. 2018 Aug 1;8(1):11785.

16.

Thallium Labeled Citrate-Coated Prussian Blue Nanoparticles as Potential Imaging Agent.

Szigeti K, Hegedűs N, Rácz K, Horváth I, Veres DS, Szöllősi D, Futó I, Módos K, Bozó T, Karlinger K, Kovács N, Varga Z, Babos M, Budán F, Padmanabhan P, Gulyás B, Máthé D.

Contrast Media Mol Imaging. 2018 Apr 26;2018:2023604. doi: 10.1155/2018/2023604. eCollection 2018.

17.

Simplified estimation of binding parameters based on image-derived reference tissue models for dopamine transporter bindings in non-human primates using [18F]FE-PE2I and PET.

Odano I, Varrone A, Hosoya T, Sakaguchi K, Gulyás B, Padmanabhan P, Ghosh KK, Yang CT, Guenther I, Wang Z, Serrano R, Chimon NG, Halldin C.

Am J Nucl Med Mol Imaging. 2017 Dec 20;7(6):246-254. eCollection 2017.

18.

Elucidation of shared and specific white matter findings underlying psychopathology clusters in schizophrenia.

Lim J, Chin R, Ho NF, Lam M, Sum MY, Collinson S, Phillips L, Lee TS, Gulyás BZ, Zhou J, Sim K.

Asian J Psychiatr. 2017 Dec;30:144-151. doi: 10.1016/j.ajp.2017.08.016. Epub 2017 Sep 1.

PMID:
28938151
19.

Engineering Concepts in Stem Cell Research.

Narayanan K, Mishra S, Singh S, Pei M, Gulyas B, Padmanabhan P.

Biotechnol J. 2017 Dec;12(12). doi: 10.1002/biot.201700066. Epub 2017 Sep 25. Review.

PMID:
28901712
20.

Theranostic Probes for Targeting Tumor Microenvironment: An Overview.

Sikkandhar MG, Nedumaran AM, Ravichandar R, Singh S, Santhakumar I, Goh ZC, Mishra S, Archunan G, Gulyás B, Padmanabhan P.

Int J Mol Sci. 2017 May 11;18(5). pii: E1036. doi: 10.3390/ijms18051036. Review.

21.

27-Hydroxycholesterol impairs neuronal glucose uptake through an IRAP/GLUT4 system dysregulation.

Ismail MA, Mateos L, Maioli S, Merino-Serrais P, Ali Z, Lodeiro M, Westman E, Leitersdorf E, Gulyás B, Olof-Wahlund L, Winblad B, Savitcheva I, Björkhem I, Cedazo-Mínguez A.

J Exp Med. 2017 Mar 6;214(3):699-717. doi: 10.1084/jem.20160534. Epub 2017 Feb 17.

22.

The small molecule AUTEN-99 (autophagy enhancer-99) prevents the progression of neurodegenerative symptoms.

Kovács T, Billes V, Komlós M, Hotzi B, Manzéger A, Tarnóci A, Papp D, Szikszai F, Szinyákovics J, Rácz Á, Noszál B, Veszelka S, Walter FR, Deli MA, Hackler L Jr, Alfoldi R, Huzian O, Puskas LG, Liliom H, Tárnok K, Schlett K, Borsy A, Welker E, Kovács AL, Pádár Z, Erdős A, Legradi A, Bjelik A, Gulya K, Gulyás B, Vellai T.

Sci Rep. 2017 Feb 16;7:42014. doi: 10.1038/srep42014.

23.

An Overview of Multimodal Neuroimaging Using Nanoprobes.

Sridhar S, Mishra S, Gulyás M, Padmanabhan P, Gulyás B.

Int J Mol Sci. 2017 Feb 1;18(2). pii: E311. doi: 10.3390/ijms18020311. Review.

24.

Current Perspective of Stem Cell Therapy in Neurodegenerative and Metabolic Diseases.

Kumar A, Narayanan K, Chaudhary RK, Mishra S, Kumar S, Vinoth KJ, Padmanabhan P, Gulyás B.

Mol Neurobiol. 2017 Nov;54(9):7276-7296. doi: 10.1007/s12035-016-0217-4. Epub 2016 Nov 4. Review.

PMID:
27815831
25.

Proteomic analysis of human saliva: An approach to find the marker protein for ovulation.

Saibaba G, Rajesh D, Muthukumar S, Sathiyanarayanan G, Padmanabhan P, Akbarsha MA, Gulyás B, Archunan G.

Reprod Biol. 2016 Dec;16(4):287-294. doi: 10.1016/j.repbio.2016.10.005. Epub 2016 Oct 29.

PMID:
27802913
26.

Structural elucidation of estrus urinary lipocalin protein (EULP) and evaluating binding affinity with pheromones using molecular docking and fluorescence study.

Rajesh D, Muthukumar S, Saibaba G, Siva D, Akbarsha MA, Gulyás B, Padmanabhan P, Archunan G.

Sci Rep. 2016 Oct 26;6:35900. doi: 10.1038/srep35900.

27.

Multi-functional nano silver: A novel disruptive and theranostic agent for pathogenic organisms in real-time.

Gopinath PM, Ranjani A, Dhanasekaran D, Thajuddin N, Archunan G, Akbarsha MA, Gulyás B, Padmanabhan P.

Sci Rep. 2016 Sep 26;6:34058. doi: 10.1038/srep34058.

28.

Guidelines to PET measurements of the target occupancy in the brain for drug development.

Takano A, Varrone A, Gulyás B, Salvadori P, Gee A, Windhorst A, Vercouillie J, Bormans G, Lammertsma AA, Halldin C.

Eur J Nucl Med Mol Imaging. 2016 Nov;43(12):2255-2262. Epub 2016 Aug 11.

29.

An automated method measures variability in P-glycoprotein and ABCG2 densities across brain regions and brain matter.

Kannan P, Schain M, Kretzschmar WW, Weidner L, Mitsios N, Gulyás B, Blom H, Gottesman MM, Innis RB, Hall MD, Mulder J.

J Cereb Blood Flow Metab. 2017 Jun;37(6):2062-2075. doi: 10.1177/0271678X16660984. Epub 2016 Jan 1.

30.

Nanoparticulate Contrast Agents for Multimodality Molecular Imaging.

Xia Y, Matham MV, Su H, Padmanabhan P, Gulyás B.

J Biomed Nanotechnol. 2016 Aug;12(8):1553-84. Review.

PMID:
29341579
31.

Nanoparticles in practice for molecular-imaging applications: An overview.

Padmanabhan P, Kumar A, Kumar S, Chaudhary RK, Gulyás B.

Acta Biomater. 2016 Sep 1;41:1-16. doi: 10.1016/j.actbio.2016.06.003. Epub 2016 Jun 2. Review.

PMID:
27265153
32.

AUTEN-67 (Autophagy Enhancer-67) Hampers the Progression of Neurodegenerative Symptoms in a Drosophila model of Huntington's Disease.

Billes V, Kovács T, Hotzi B, Manzéger A, Tagscherer K, Komlós M, Tarnóci A, Pádár Z, Erdős A, Bjelik A, Legradi A, Gulya K, Gulyás B, Vellai T.

J Huntingtons Dis. 2016 May 7;5(2):133-47. doi: 10.3233/JHD-150180.

PMID:
27163946
33.

Biocompatible branched copolymer nanoparticles prepared by RAFT polymerization as MRI/PET bimodal tracers.

Yang CT, Tao H, Jackson AW, Chandrasekharan P, Padmanabhan P, Gulyás B, Halldin C.

EJNMMI Phys. 2015 Dec;2(Suppl 1):A90. doi: 10.1186/2197-7364-2-S1-A90. No abstract available.

34.

Brain PET measurement of PDE10A occupancy by TAK-063, a new PDE10A inhibitor, using [11 C]T-773 in nonhuman primates.

Takano A, Stepanov V, Nakao R, Amini N, Gulyás B, Kimura H, Halldin C.

Synapse. 2016 Jun;70(6):253-63. doi: 10.1002/syn.21896. Epub 2016 Mar 4.

PMID:
26878349
35.

Nanoparticle Functionalization and Its Potentials for Molecular Imaging.

Thiruppathi R, Mishra S, Ganapathy M, Padmanabhan P, Gulyás B.

Adv Sci (Weinh). 2016 Dec 16;4(3):1600279. doi: 10.1002/advs.201600279. eCollection 2017 Mar. Review.

36.

AUTEN-67, an autophagy-enhancing drug candidate with potent antiaging and neuroprotective effects.

Papp D, Kovács T, Billes V, Varga M, Tarnóci A, Hackler L Jr, Puskás LG, Liliom H, Tárnok K, Schlett K, Borsy A, Pádár Z, Kovács AL, Hegedűs K, Juhász G, Komlós M, Erdős A, Gulyás B, Vellai T.

Autophagy. 2016;12(2):273-86. doi: 10.1080/15548627.2015.1082023.

37.

ABC transporter-dependent brain uptake of the 5-HT1B receptor radioligand [ (11)C]AZ10419369: a comparative PET study in mouse, rat, and guinea pig.

Tóth M, Häggkvist J, Varrone A, Finnema SJ, Doorduin J, Tokunaga M, Higuchi M, Gulyás B, Halldin C.

EJNMMI Res. 2014 Dec;4(1):64. doi: 10.1186/s13550-014-0064-0. Epub 2014 Nov 30.

38.

Positron Emission Tomography studies with [11C]PBR28 in the Healthy Rodent Brain: Validating SUV as an Outcome Measure of Neuroinflammation.

Tóth M, Doorduin J, Häggkvist J, Varrone A, Amini N, Halldin C, Gulyás B.

PLoS One. 2015 May 21;10(5):e0125917. doi: 10.1371/journal.pone.0125917. eCollection 2015.

39.

Astrocytosis precedes amyloid plaque deposition in Alzheimer APPswe transgenic mouse brain: a correlative positron emission tomography and in vitro imaging study.

Rodriguez-Vieitez E, Ni R, Gulyás B, Tóth M, Häggkvist J, Halldin C, Voytenko L, Marutle A, Nordberg A.

Eur J Nucl Med Mol Imaging. 2015 Jun;42(7):1119-32. doi: 10.1007/s00259-015-3047-0. Epub 2015 Apr 17.

40.

Evaluation of a novel PDE10A PET radioligand, [(11) C]T-773, in nonhuman primates: brain and whole body PET and brain autoradiography.

Takano A, Stepanov V, Gulyás B, Nakao R, Amini N, Miura S, Kimura H, Taniguchi T, Halldin C.

Synapse. 2015 Jul;69(7):345-55. doi: 10.1002/syn.21821. Epub 2015 May 21.

PMID:
25892433
41.

A PET study comparing receptor occupancy by five selective cannabinoid 1 receptor antagonists in non-human primates.

Hjorth S, Karlsson C, Jucaite A, Varnäs K, Wählby Hamrén U, Johnström P, Gulyás B, Donohue SR, Pike VW, Halldin C, Farde L.

Neuropharmacology. 2016 Feb;101:519-30. doi: 10.1016/j.neuropharm.2015.03.002. Epub 2015 Mar 17.

42.

Molecular Imaging of PDE10A Knockout Mice with a Novel PET Radiotracer: [(11)C]T-773.

Tóth M, Häggkvist J, Stepanov V, Takano A, Nakao R, Amini N, Miura S, Kimura H, Taniguchi T, Gulyás B, Halldin C.

Mol Imaging Biol. 2015 Aug;17(4):445-9. doi: 10.1007/s11307-015-0822-z.

PMID:
25622810
43.

Acute neuroinflammation in a clinically relevant focal cortical ischemic stroke model in rat: longitudinal positron emission tomography and immunofluorescent tracking.

Tóth M, Little P, Arnberg F, Häggkvist J, Mulder J, Halldin C, Gulyás B, Holmin S.

Brain Struct Funct. 2016 Apr;221(3):1279-90. doi: 10.1007/s00429-014-0970-y. Epub 2015 Jan 20.

PMID:
25601153
44.

In vivo occupancy of the 5-HT1A receptor by a novel pan 5-HT1(A/B/D) receptor antagonist, GSK588045, using positron emission tomography.

Comley RA, van der Aart J, Gulyás B, Garnier M, Iavarone L, Halldin C, Rabiner EA.

Neuropharmacology. 2015 May;92:44-8. doi: 10.1016/j.neuropharm.2014.11.017. Epub 2014 Dec 2.

PMID:
25476970
45.

The gut microbiota influences blood-brain barrier permeability in mice.

Braniste V, Al-Asmakh M, Kowal C, Anuar F, Abbaspour A, Tóth M, Korecka A, Bakocevic N, Ng LG, Kundu P, Gulyás B, Halldin C, Hultenby K, Nilsson H, Hebert H, Volpe BT, Diamond B, Pettersson S.

Sci Transl Med. 2014 Nov 19;6(263):263ra158. doi: 10.1126/scitranslmed.3009759. Erratum in: Sci Transl Med. 2014 Dec 10;6(266):266er7. Guan, Ng Lai [corrected to Ng, Lai Guan].

46.

Exploration of salivary proteins in buffalo: an approach to find marker proteins for estrus.

Muthukumar S, Rajkumar R, Rajesh D, Saibaba G, Liao CC, Archunan G, Padmanabhan P, Gulyas B.

FASEB J. 2014 Nov;28(11):4700-9. doi: 10.1096/fj.14-252288. Epub 2014 Aug 11.

PMID:
25114174
47.

EANM guideline for the preparation of an Investigational Medicinal Product Dossier (IMPD).

Todde S, Windhorst AD, Behe M, Bormans G, Decristoforo C, Faivre-Chauvet A, Ferrari V, Gee AD, Gulyas B, Halldin C, Peitl PK, Koziorowski J, Mindt TL, Sollini M, Vercouillie J, Ballinger JR, Elsinga PH.

Eur J Nucl Med Mol Imaging. 2014 Nov;41(11):2175-85. doi: 10.1007/s00259-014-2866-8.

PMID:
25081821
48.

Decrease of mGluR5 receptor density goes parallel with changes in enkephalin and substance P immunoreactivity in Huntington's disease: a preliminary investigation in the postmortem human brain.

Gulyás B, Sovago J, Gomez-Mancilla B, Jia Z, Szigeti C, Gulya K, Schumacher M, Maguire RP, Gasparini F, Halldin C.

Brain Struct Funct. 2015 Sep;220(5):3043-51. doi: 10.1007/s00429-014-0812-y. Epub 2014 Jun 28.

PMID:
24969128
49.

A radiometabolite study of the serotonin transporter PET radioligand [(11)C]MADAM.

Gourand F, Emond P, Bergström JP, Takano A, Gulyás B, Guilloteau D, Barré L, Halldin C.

Nucl Med Biol. 2014 Jul;41(6):501-6. doi: 10.1016/j.nucmedbio.2014.03.022. Epub 2014 Apr 2.

PMID:
24857865
50.

MicroRNAs -the next generation therapeutic targets in human diseases.

Srinivasan S, Selvan ST, Archunan G, Gulyas B, Padmanabhan P.

Theranostics. 2013 Nov 29;3(12):930-42. doi: 10.7150/thno.7026. Review.

Supplemental Content

Loading ...
Support Center